Skip to main content

Table 3 Influence of CDKN2 deletion on complete molecular response (CMR)

From: Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia

  Patients (dele/wild) CDKN2 deletion Non CDKN2 deletion P value
After inductiona 39/85 6 (15.4 %) 28 (32.9 %) 0.042
Pre-Allo-HSCTa 34/62 18 (52.9 %) 48 (77.4 %) 0.013
Post-Allo-HSCT 31/58 27 (87 %) 54 (93.1 %) 0.442
  1. Allo-HSCT allogeneic hematopoietic stem cell transplantation
  2. aComparison between CDKN2 deletion carriers and non-carriers